Benyamin Lukito

Learn More
AIM To identify the distribution of hepatitis B virus (HBV) subgenotype and basal core promoter (BCP) mutations among patients with HBV-associated liver disease in Indonesia. METHODS Patients with chronic hepatitis (CH, n = 61), liver cirrhosis (LC, n = 62), and hepatocellular carcinoma (HCC, n = 48) were included in this study. HBV subgenotype was(More)
AIM To identify the prevalence of hepatitis B e antigen (HBeAg) and to assess the association of hepatitis B virus (HBV) core promoter mutations and viral load in Indonesian patients. METHODS Sixty-four patients with chronic hepatitis, 65 with liver cirrhosis and 50 with hepatocellular carcinoma were included in this study. HBeAg and hepatitis B e(More)
The molecular epidemiological study of hepatitis B virus (HBV) in Indonesia is still limited. This study was aimed to identify the prevalence of HBV pre-S deletion/insertion mutations, and to assess the association of pre-S deletion mutation with liver disease progression in Indonesia. Pre-S mutations were identified by direct sequencing. Of the 265(More)
AIM To identify the prevalence of pre-S2 start codon mutations and to assess their association with liver disease progression. METHODS The mutations were identified by direct sequencing from 73 asymptomatic carriers, 66 chronic hepatitis (CH), 66 liver cirrhosis (LC) and 63 hepatocellular carcinoma (HCC) patients. Statistical significances were determined(More)
Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan/Siloam Hospital, Lippo Village, Jl. Siloam No.6, Tangerang, Indonesia Mochtar Riady Institute for Nanotechnology, Jl. Boulevard Jenderal Sudirman 1668, Lippo Village, Tangerang, Banten, Indonesia Klinik Hati Prof. Ali Sulaiman, Jl. Cilamaya No. 46, Jakarta Pusat, Indonesia(More)
  • 1